DPP-4 inhibitor induces FGF21 expression via sirtuin 1 signaling and improves myocardial energy metabolism

Dipeptidyl peptidase-4 (DPP-4) inhibitors are widely used incretin-based therapy for the treatment of type 2 diabetes. We investigated the cardioprotective effect of a DPP-4 inhibitor, vildagliptin (vilda), on myocardial metabolism and cardiac performance under pressure overload. Mice were treated w...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Heart Vessels
Autors principals: Furukawa, Nozomi, Koitabashi, Norimichi, Matsui, Hiroki, Sunaga, Hiroaki, Umbarawan, Yogi, Syamsunarno, Mas Rizky A. A., Yamaguchi, Aiko, Obokata, Masaru, Hanaoka, Hirofumi, Yokoyama, Tomoyuki, Kurabayashi, Masahiko
Format: Artigo
Idioma:Inglês
Publicat: Springer Japan 2020
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7788045/
https://ncbi.nlm.nih.gov/pubmed/33073318
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00380-020-01711-z
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars